RESUMEN
This work describes the design of novel Cu(II) complexes and their application in the photocatalytic degradation of methylene blue (MB). The same photocatalyst exhibits antibacterial activity against Escherichia coli (gram-negative) and Bacillus circulans (gram-positive). The characterisation of the photocatalysts has been done by several up-to-date physical methods. The rationale behind the photocatalysts' beneficial intervention is discussed in this study. Statistical analysis of the degradation of MB is done using a one-way ANOVA, and the significance of means is determined by a multiple comparison test using Turkey HSD. Also, the degradation of MB follows pseudo first-order kinetics with high correlation coefficient values (R2 > 0.95), making them useful as simple and low-cost organic dye degradation agents.
Asunto(s)
Azul de Metileno , Bases de Schiff , Antibacterianos/farmacología , Catálisis , ColorantesRESUMEN
Periodontal ligament (PDL) cells maintain the attachment of the tooth to alveolar bone. These cells reside at a site in which they are challenged frequently by bacterial products and proinflammatory cytokines, such as interleukin-1beta (IL-1beta), during infections. In our initial studies we observed that IL-1beta down-regulates the osteoblast-like characteristics of PDL cells in vitro. Therefore, we examined the functional significance of the loss of the PDL cell's osteoblast-like characteristics during inflammation. In this report we show that, during inflammation, IL-1beta can modulate the phenotypic characteristics of PDL cells to a more functionally significant lipopolysaccharide (LPS)-responsive phenotype. In a healthy periodontium PDL cells exhibit an osteoblast-like phenotype and are unresponsive to gram-negative bacterial LPS. Treatment of PDL cells with IL-1beta inhibits the expression of their osteoblast-like characteristics, as assessed by the failure to express transforming growth factor beta1 (TGF-beta1) and proteins associated with mineralization, such as alkaline phosphatase and osteocalcin. As a consequence of this IL-1beta-induced phenotypic change, PDL cells become responsive to LPS and synthesize proinflammatory cytokines. The IL-1beta-induced phenotypic changes in PDL cells were transient, as removal of IL-1beta from PDL cell cultures resulted in reacquisition of their osteoblast-like characteristics and lack of LPS responsiveness. The IL-1beta-induced phenotypic changes occurred at concentrations that are frequently observed in tissue exudates during periodontal inflammation (0.05 to 5 ng/ml). The results suggest that, during inflammation in vivo, IL-1beta may modulate PDL cell functions, allowing PDL cells to participate directly in the disease process by assuming LPS responsiveness at the expense of their normal structural properties and functions.
Asunto(s)
Interleucina-1/farmacología , Ligamento Periodontal/efectos de los fármacos , Periodontitis/inmunología , Adulto , Humanos , Lipopolisacáridos/farmacología , Masculino , Osteoblastos/efectos de los fármacos , Osteoblastos/fisiología , Ligamento Periodontal/citología , Ligamento Periodontal/fisiología , Fenotipo , Proteínas Recombinantes/farmacologíaRESUMEN
We have examined the ability of gingival fibroblasts (GF) to participate in inflammatory response and function as accessory immune cells. The accessory immune function of GF cells was evaluated by their ability to elaborate proinflammatory cytokines following stimulation with lipopolysaccharides and interleukin-1 beta (IL-1 beta). Using three separate clonally derived and characterized human gingival fibroblast (GF) cell lines, we demonstrate that LPS from Actinobacillus actinomycetemcomitans (Aa) and Escherichia coli (Ec) induce mRNA and synthesis of proinflammatory cytokines, IL-1 beta, IL-6 and IL-8. IL-1 beta activation of GF cells showed that IL-1 beta non only induces the expression of IL-6, IL-8 and TNF-alpha, but also acts in an autocrine manner of GF cells and induces IL-1 beta expression. Furthermore, the continuous presence of IL-1 beta in GF cell cultures did not down regulate the response of GF cells to IL-1 beta. Pretreatment of GF cells with IL-1 beta resulted in the enhanced synthesis of TNF-alpha in response to additional IL-1 beta. These findings indicate that GF cells, in addition to providing structural support, may also function as accessory immune cells and play an important role in the initial inflammatory reaction as well as in the amplification of immune response.